6
Participants
Start Date
August 31, 2011
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
[14C] AT1001
150 mg of \[14C\] labelled AT1001 will be administered as a solution (prepared by weighing 150 mg of AT1001 powder and dissolving in 100 mL of water). The entire solution will be swallowed orally. After ingestion of study medication, the dosing bottle will be rinsed with 50 mL of water and this will be ingested by the subject. This rinse procedure should be performed twice. Following the second rinse ingestion, the subjects should be instructed to drink additional water to bring the total volume ingested to 240 mL.
Lead Sponsor
Amicus Therapeutics
INDUSTRY